Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Endocrine 1Dermatologic 1CNS 1Breast 1

Conditions

Glioblastoma 14Brain Neoplasms 11Gliosarcoma 8Glioma 7Oligodendroglioma 5Central Nervous System Neoplasms 5Astrocytoma 5Neoplasm Metastasis 4Neuroblastoma 3Breast Neoplasms 3Sarcoma 2Prostatic Neoplasms 2Pinealoma 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Soft Tissue Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Pheochromocytoma 1Pharyngeal Neoplasms 1Paraganglioma, Extra-Adrenal 1Pancreatic Neoplasms 1Osteosarcoma 1Neurofibromatosis 2 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors, Primitive 1Neoplasms, Mesothelial 1

Interventions

tipifarnib 1temsirolimus 1pentetreotide 1Vinorelbine 1Trastuzumab 1Sirolimus 1Oxaliplatin 1Leucovorin 1Floxuridine 1Fentanyl 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Islet Cell × temsirolimus × CNS × Clear all
NCT01155258 2016-06-13

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

University of Southern California

Phase 1 Completed
19 enrolled
BreastCNSDermatologicEndocrineGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Paraganglioma, Extra-Adrenal, Pheochromocytoma, Prostatic Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Carcinoma, Islet Cell, Carcinoma, Medullary, Breast Neoplasms, Male, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡